Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...
The FDA has granted Fast Track designation to LPCN 1148 for the treatment of sarcopenia in patients with decompensated cirrhosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback